Platelet lysate coating on scaffolds directly and indirectly enhances cell migration, improving bone and blood vessel formation.

[1]  Philippe Bierling,et al.  In vivo and in vitro comparison of three different allografts vitalized with human mesenchymal stromal cells. , 2012, Tissue engineering. Part A.

[2]  S. Falco The discovery of placenta growth factor and its biological activity , 2012, Experimental & Molecular Medicine.

[3]  C. Liang,et al.  Expression of RANKL/OPG during bone remodeling in vivo. , 2011, Biochemical and biophysical research communications.

[4]  S. Giannini,et al.  Mesenchymal stem cells and platelet lysate in fibrin or collagen scaffold promote non‐cemented hip prosthesis integration , 2011, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[5]  Rozalia Dimitriou,et al.  Bone regeneration: current concepts and future directions , 2011, BMC medicine.

[6]  A. Matsumura,et al.  Enhanced bone formation using hydroxyapatite ceramic coated with fibroblast growth factor-2. , 2010, Acta biomaterialia.

[7]  A. Villa,et al.  Characterization of platelet lysate cultured mesenchymal stromal cells and their potential use in tissue-engineered osteogenic devices for the treatment of bone defects. , 2010, Tissue engineering. Part C, Methods.

[8]  Richard O C Oreffo,et al.  The effect of the delivery of vascular endothelial growth factor and bone morphogenic protein-2 to osteoprogenitor cell populations on bone formation. , 2010, Biomaterials.

[9]  D. Heymann,et al.  Mechanisms of bone repair and regeneration. , 2009, Trends in molecular medicine.

[10]  C. Ye,et al.  Combination of stromal-derived factor-1alpha and vascular endothelial growth factor gene-modified endothelial progenitor cells is more effective for ischemic neovascularization. , 2009, Journal of vascular surgery.

[11]  S. Meuth,et al.  Platelet derived bFGF mediates vascular integrative mechanisms of mesenchymal stem cells in vitro. , 2009, Journal of molecular and cellular cardiology.

[12]  A. Reinisch,et al.  Humanized large-scale expanded endothelial colony-forming cells function in vitro and in vivo. , 2009, Blood.

[13]  Pamela J VandeVord,et al.  Improved tissue-engineered bone regeneration by endothelial cell mediated vascularization. , 2009, Biomaterials.

[14]  I. Martin,et al.  Platelet lysate as a serum substitute for 2D static and 3D perfusion culture of stromal vascular fraction cells from human adipose tissue. , 2009, Tissue engineering. Part A.

[15]  M. Robiony,et al.  Osteogenesis distraction and platelet-rich plasma: combined use in restoration of severe atrophic mandible. Long-term results. , 2008, Clinical oral implants research.

[16]  J. Kanczler,et al.  Osteogenesis and angiogenesis: the potential for engineering bone. , 2008, European cells & materials.

[17]  M. Gawaz,et al.  Platelets in regenerative medicine , 2008, Basic Research in Cardiology.

[18]  J. Folkman,et al.  Angiogenesis is regulated by a novel mechanism: pro- and antiangiogenic proteins are organized into separate platelet alpha granules and differentially released. , 2008, Blood.

[19]  U. Albisinni,et al.  Enhanced tibial osteotomy healing with use of bone grafts supplemented with platelet gel or platelet gel and bone marrow stromal cells. , 2007, The Journal of bone and joint surgery. American volume.

[20]  Tain‐Hsiung Chen,et al.  Early experience and results of bone graft enriched with autologous platelet gel for recalcitrant nonunions of lower extremity. , 2007, The Journal of trauma.

[21]  M. Introna,et al.  Human platelet lysate allows expansion and clinical grade production of mesenchymal stromal cells from small samples of bone marrow aspirates or marrow filter washouts , 2007, Bone Marrow Transplantation.

[22]  P. Robey,et al.  Formation of hematopoietic territories and bone by transplanted human bone marrow stromal cells requires a critical cell density. , 2007, Experimental hematology.

[23]  C. Kielty,et al.  Vascular endothelial growth factor can signal through platelet-derived growth factor receptors , 2007, The Journal of cell biology.

[24]  D. Smrke,et al.  Allogeneic Platelet Gel with Autologous Cancellous Bone Graft for the Treatment of a Large Bone Defect , 2007, European Surgical Research.

[25]  A. Vloon,et al.  Platelet-rich plasma: quantification of growth factor levels and the effect on growth and differentiation of rat bone marrow cells. , 2006, Tissue engineering.

[26]  J. Granada,et al.  Potential role of activated platelets in homing of human endothelial progenitor cells to subendothelial matrix , 2006, Thrombosis and Haemostasis.

[27]  T. Rabelink,et al.  Fibrin and Activated Platelets Cooperatively Guide Stem Cells to a Vascular Injury and Promote Differentiation Towards an Endothelial Cell Phenotype , 2006, Arteriosclerosis, thrombosis, and vascular biology.

[28]  Uwe Mehlhorn,et al.  Basic Fibroblast Growth Factor Controls Migration in Human Mesenchymal Stem Cells , 2006, Stem cells.

[29]  D. Busch,et al.  Platelets secrete stromal cell–derived factor 1α and recruit bone marrow–derived progenitor cells to arterial thrombi in vivo , 2006, The Journal of experimental medicine.

[30]  U. Heinzmann,et al.  Adherent Platelets Recruit and Induce Differentiation of Murine Embryonic Endothelial Progenitor Cells to Mature Endothelial Cells In Vitro , 2006, Circulation research.

[31]  X. Holy,et al.  Platelet lysates promote mesenchymal stem cell expansion: A safety substitute for animal serum in cell‐based therapy applications , 2005, Journal of cellular physiology.

[32]  Michael T Longaker,et al.  Angiogenesis Is Required for Successful Bone Induction During Distraction Osteogenesis , 2005, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  M. Matsuda,et al.  Adiponectin increases bone mass by suppressing osteoclast and activating osteoblast. , 2005, Biochemical and biophysical research communications.

[34]  I. Martineau,et al.  Platelet-rich Plasmas: Growth Factor Content and Roles in Wound Healing , 2005, Journal of dental research.

[35]  M. Reynolds,et al.  Evaluation of the Adjunctive Benefits of Platelet-Rich Plasma in Subantral Sinus Augmentation , 2005, The Journal of craniofacial surgery.

[36]  D. Mooney,et al.  Combined Angiogenic and Osteogenic Factor Delivery Enhances Bone Marrow Stromal Cell‐Driven Bone Regeneration , 2004, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[37]  O. Kilian,et al.  Effects of platelet growth factors on human mesenchymal stem cells and human endothelial cells in vitro. , 2004, European journal of medical research.

[38]  R. Schmelzeisen,et al.  Tissue-engineered bone for maxillary sinus augmentation. , 2004, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[39]  S. T. Dheen,et al.  Interactions of Chemokines and Chemokine Receptors Mediate the Migration of Mesenchymal Stem Cells to the Impaired Site in the Brain After Hypoglossal Nerve Injury , 2004, Stem cells.

[40]  G. Coen Leptin and bone metabolism. , 2004, Journal of nephrology.

[41]  R. Carano,et al.  Angiogenesis and bone repair. , 2003, Drug discovery today.

[42]  C. Maiorana,et al.  Maxillary sinus augmentation with anorganic bovine bone (Bio-Oss) and autologous platelet-rich plasma: preliminary clinical and histologic evaluations. , 2003, The International journal of periodontics & restorative dentistry.

[43]  Jay R Lieberman,et al.  The role of growth factors in the repair of bone. Biology and clinical applications. , 2002, The Journal of bone and joint surgery. American volume.

[44]  M. Robiony,et al.  Osteogenesis distraction and platelet-rich plasma for bone restoration of the severely atrophic mandible: preliminary results. , 2002, Journal of oral and maxillofacial surgery : official journal of the American Association of Oral and Maxillofacial Surgeons.

[45]  W. Puhl,et al.  Vascular endothelial growth factor stimulates chemotactic migration of primary human osteoblasts. , 2002, Bone.

[46]  K. Zinn,et al.  Analysis of Ti-6Al-4V implants placed with fibroblast growth factor 1 in rat tibiae. , 2001, The International journal of oral & maxillofacial implants.

[47]  S. Rafii,et al.  Mobilization of Endothelial and Hematopoietic Stem and Progenitor Cells by Adenovector‐Mediated Elevation of Serum Levels of SDF‐1, VEGF, and Angiopoietin‐1 , 2001, Annals of the New York Academy of Sciences.

[48]  M. Reynolds,et al.  Alveolar ridge and sinus augmentation utilizing platelet-rich plasma in combination with freeze-dried bone allograft: case series. , 2000, Journal of periodontology.

[49]  A. Meunier,et al.  Tissue-engineered bone regeneration , 2000, Nature Biotechnology.

[50]  A Boyde,et al.  Autologous bone marrow stromal cells loaded onto porous hydroxyapatite ceramic accelerate bone repair in critical-size defects of sheep long bones. , 2000, Journal of biomedical materials research.

[51]  J. Isner,et al.  VEGF contributes to postnatal neovascularization by mobilizing bone marrow‐derived endothelial progenitor cells , 1999, The EMBO journal.

[52]  G. Neufeld,et al.  Vascular endothelial growth factor (VEGF) and its receptors , 1999, FASEB journal : official publication of the Federation of American Societies for Experimental Biology.

[53]  J. Isner,et al.  Chemotactic Properties of Angiopoietin-1 and -2, Ligands for the Endothelial-specific Receptor Tyrosine Kinase Tie2* , 1998, The Journal of Biological Chemistry.

[54]  V. Goldberg,et al.  The Effect of Implants Loaded with Autologous Mesenchymal Stem Cells on the Healing of Canine Segmental Bone Defects* , 1998, The Journal of bone and joint surgery. American volume.

[55]  R. Marx,et al.  Platelet-rich plasma: Growth factor enhancement for bone grafts. , 1998, Oral surgery, oral medicine, oral pathology, oral radiology, and endodontics.

[56]  I. Martin,et al.  Fibroblast growth factor-2 supports ex vivo expansion and maintenance of osteogenic precursors from human bone marrow. , 1997, Endocrinology.

[57]  W. Risau,et al.  Mechanisms of angiogenesis , 1997, Nature.

[58]  N. Ferrara,et al.  The biology of vascular endothelial growth factor. , 1997, Endocrine reviews.

[59]  A. Caplan,et al.  Osteochondrogenic potential of marrow mesenchymal progenitor cells exposed to TGF‐β1 or PDGF‐BB as assayed in vivo and in vitro , 1996, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[60]  T A Einhorn,et al.  Enhancement of fracture-healing. , 1995, The Journal of bone and joint surgery. American volume.

[61]  S. Gronthos,et al.  The growth factor requirements of STRO-1-positive human bone marrow stromal precursors under serum-deprived conditions in vitro. , 1995, Blood.

[62]  C. Hou,et al.  Insulin promotes bone formation in augmented maxillary sinus in diabetic rabbits , 2012 .

[63]  Philippe Bierling,et al.  Osteoblastic differentiation of human mesenchymal stem cells with platelet lysate. , 2010, Biomaterials.

[64]  R. Cancedda,et al.  The development of tissue-engineered bone of different origin through endochondral and intramembranous ossification following the implantation of mesenchymal stem cells and osteoblasts in a murine model. , 2010, Biomaterials.

[65]  M. Alobera-Gracia,et al.  Physiological bases of bone regeneration I. Histology and physiology of bone tissue. , 2006, Medicina oral, patologia oral y cirugia bucal.

[66]  W. Schaper,et al.  An Engineered Heparin-Binding Form of VEGF-E (hbVEGF-E). Biological effects in vitro and mobilizatiion of precursor cells , 2004, Angiogenesis.

[67]  E. Livne,et al.  Bone defect repair in rat tibia by TGF-β1 and IGF-1 released from hydrogel scaffold , 2004, Cell and Tissue Banking.

[68]  M. Sefton,et al.  Tissue engineering. , 1998, Journal of cutaneous medicine and surgery.

[69]  B. Weksler,et al.  Characterization of a newly established human bone marrow endothelial cell line: distinct adhesive properties for hematopoietic progenitors compared with human umbilical vein endothelial cells. , 1997, Laboratory investigation; a journal of technical methods and pathology.

[70]  J. Vacanti,et al.  Tissue engineering : Frontiers in biotechnology , 1993 .